Navigation Links
NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
Date:9/19/2008

ROCKVILLE, Md., Sept. 19 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the 2008 UBS Global Life Sciences Conference in New York, NY. The conference is being held September 22-25, 2008 at The Grand Hyatt Hotel. Dr. Singhvi will be presenting Thursday, September 25, 2008 at 10:30 am. Eastern Time. Dr. Singhvi will provide an overview of the company's strategy, research and development progress.

A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
2. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
3. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
4. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
5. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
8. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
9. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
10. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
11. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--QuestDiagnosticsIncorporated(NYSE: D...informationandservices,announcedthatitisscheduledt...nceinNewYorkCity.ThepresentationisscheduledforWedn...uringtheconference,thecompanywillreaffirmits2009gu...ometoexceed18%ofrevenues,anddilutedearningspershar...
(Date:11/24/2009)...rstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS ...erJaffrayHealthcareConferenceonTuesday,December1,2...heldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pre...anoverviewofAnadysanditsclinicaldevelopmentprogram...illbesimultaneouslywebcastandcanbeaccessedontheInv...
(Date:11/24/2009).../--Inadditiontofamily,friendsandhealth,cancersurvi...nksgivinggratitudelist. ,, "Theyheardthefactsan...onday,sverdictstotaling$103millionindamagesagainst...omennationwidewhohavesuedWyethandPfizerpharmaceuti...pro.Wisneskiandtheothervictimsofhormonetherapyhave...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 1ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 3ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 4ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 5Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 1Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 2Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 3Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 4Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 5
..., Colo., Oct. 3 Tapestry,Pharmaceuticals, Inc. (N...ed,a Phase 2 open- label, multi-center study of TP... This is the second Phase 2 trial exploring the,ac...t Phase 2 trial began,earlier this year in advance...available taxanes are not approved for pancreatic ...
...Dose of Estradiol Shown to Be Safe and Effective f...n, WEST PALM BEACH, Fla., Oct. 3 A study present...merican Menopause Society (NAMS),revealed that Div... the,frequency and severity of moderate to severe ...data presented at the meeting found that Divigel(R...
Other Medicine Technology:Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes 2
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheBartleHallConventionCenter...iconDec.9-10,whenKansasCityhoststhelatestinaseries...sfreecliniceventhasthepotentialtobethebiggestoneye...dbeheldonweekdaysinsteadofoveraweekend,"SheriWood,...dpresidentoftheNationalAssociationofFreeClinics(NA...
(Date:11/25/2009)...if.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceut...anywillhosttwoinvestoreventsinDecember: ,, AS...0a.m.ET ,, Principalinvestigatorswilldiscussd...d/orrefractorymultiplemyeloma,asfeaturedatthe51stA...ositioninNewOrleans,LA.Theteleconferencewillbegina...
(Date:11/25/2009)...ARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...sandsoftwareandCalgaryScientificInc.,aleadingprovi...ebversionofAegis(TM)Breast4DAdvancedVisualizations...ulyzero-footprintWebclientbasedmedicalimagingoffer...ormallowsforzero-footprintaccess-requiringnosoftwa...
(Date:11/25/2009).../PRNewswire/-SentinelleMedicalInc.,aleadingmanufac...arelaunchesasuiteofnewleadingedgeclinicalapplicati...hisyear,sRadiologicalSocietyofNorthAmerica(RSNA)an...allA).Theapplicationsleveragetheuniquehighqualityi...oilsandsupportmultipleimagingmodalitiesformulti-pa...
(Date:11/25/2009)...f.,Nov.25/PRNewswire/--Thanksgivingmealswillbedeli...terLongBeachareathankstoFaithInAction/VolunteerAct...AH),adivisionofSCANHealthPlan.Formorethan17yearsth...deliverwarmThanksgivingmealstoseniorsinneedinLongB...ndsurroundingcities. ,, "Ourwarmholidaymealsare...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...s anti-cancer drug `Tarceva' (erlotinib), which `p.../, suffering from lung cancer. The Managing D...taken once a day and has the potential to treat ma...ne prior chemotherapy regiment. Dr. Telang al...
... ?6.2bn upgrade of the NHS IT system has to be th...ter Weekly magazine said that the group of academi...he government responded by saying that the plan wa... 2012. However the experts say that this means tha...
... ahs been found that survival rates following the ...-fold when emergency medical// personnel used a ne...na Sarver Heart Center. Cardiocerebral Resuscita... Kellum, MD, leading author of the study report, "...
...ssuming the role of a doctor but pretty bad at adm... Queensland University// of Technology has reveale...their children an incorrect dose of medication, al... risen from 12% in 1987 to 33 per cent in 2002.It ...
... Russell and her six-year-old daughter, Megan. Now...port// which details widespread failures by the au...m his point of view he says that the disclosure of...nother of Mrs Russell's daughters, Josie, who surv...
...esday gave an optimistic report about the world’s ...rizon// included worries about the impact of a pot...utbreak in humans could cause high absenteeism in ... international finance systems, the Global Financi...
Other Medicine News:Health News:Paramedics save more lives following unconventional rules 2Health News:IMF considers Bird Flu to be a Dark Cloud 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: